A detailed history of Voya Investment Management LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 68,444 shares of KRYS stock, worth $10.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
68,444
Previous 72,877 6.08%
Holding current value
$10.7 Million
Previous $13.4 Million 7.0%
% of portfolio
0.02%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$174.7 - $213.66 $774,445 - $947,154
-4,433 Reduced 6.08%
68,444 $12.4 Million
Q2 2024

Dec 03, 2024

BUY
$153.12 - $183.64 $678,780 - $814,076
4,433 Added 6.48%
72,877 $13.4 Million
Q2 2024

Aug 14, 2024

BUY
$153.12 - $183.64 $2.13 Million - $2.55 Million
13,896 Added 23.56%
72,877 $13.4 Million
Q1 2024

Dec 06, 2024

SELL
$108.01 - $179.35 $1.02 Million - $1.7 Million
-9,463 Reduced 13.83%
58,981 $10.5 Million
Q1 2024

May 15, 2024

BUY
$108.01 - $179.35 $1.42 Million - $2.35 Million
13,128 Added 28.63%
58,981 $10.5 Million
Q4 2023

Feb 14, 2024

BUY
$96.0 - $128.29 $1.67 Million - $2.23 Million
17,413 Added 61.23%
45,853 $5.69 Million
Q3 2023

Nov 14, 2023

SELL
$108.51 - $130.22 $1.4 Million - $1.68 Million
-12,900 Reduced 31.2%
28,440 $3.3 Million
Q2 2023

Aug 14, 2023

BUY
$78.48 - $130.32 $642,437 - $1.07 Million
8,186 Added 24.69%
41,340 $4.85 Million
Q1 2023

May 15, 2023

SELL
$72.39 - $84.27 $2.13 Million - $2.48 Million
-29,455 Reduced 47.05%
33,154 $2.65 Million
Q4 2022

Feb 14, 2023

SELL
$63.14 - $79.9 $80,819 - $102,272
-1,280 Reduced 2.0%
62,609 $4.96 Million
Q3 2022

Mar 03, 2023

BUY
$64.85 - $82.4 $83,008 - $105,472
1,280 Added 2.04%
63,889 $4.45 Million
Q3 2022

Nov 14, 2022

BUY
$64.85 - $82.4 $3.64 Million - $4.62 Million
56,111 Added 721.41%
63,889 $4.45 Million
Q2 2022

Aug 15, 2022

BUY
$48.93 - $73.47 $37,480 - $56,278
766 Added 10.92%
7,778 $511,000
Q4 2021

Feb 14, 2022

SELL
$39.81 - $88.24 $1.96 Million - $4.34 Million
-49,223 Reduced 87.53%
7,012 $490,000
Q3 2021

Nov 15, 2021

SELL
$52.01 - $71.77 $222,602 - $307,175
-4,280 Reduced 7.07%
56,235 $2.94 Million
Q2 2021

Aug 16, 2021

SELL
$62.14 - $81.82 $1.84 Million - $2.42 Million
-29,555 Reduced 32.81%
60,515 $4.12 Million
Q1 2021

May 17, 2021

SELL
$59.42 - $85.46 $844,536 - $1.21 Million
-14,213 Reduced 13.63%
90,070 $6.94 Million
Q4 2020

Feb 16, 2021

SELL
$40.64 - $61.38 $332,841 - $502,702
-8,190 Reduced 7.28%
104,283 $6.26 Million
Q3 2020

Nov 16, 2020

BUY
$37.76 - $48.49 $817,919 - $1.05 Million
21,661 Added 23.85%
112,473 $4.84 Million
Q2 2020

Aug 14, 2020

BUY
$37.03 - $60.0 $704,199 - $1.14 Million
19,017 Added 26.49%
90,812 $3.76 Million
Q1 2020

May 15, 2020

SELL
$35.02 - $65.64 $327,472 - $613,799
-9,351 Reduced 11.52%
71,795 $3.1 Million
Q4 2019

Feb 14, 2020

SELL
$33.17 - $65.23 $3.91 Million - $7.7 Million
-118,005 Reduced 59.25%
81,146 $4.49 Million
Q3 2019

Nov 14, 2019

BUY
$34.72 - $51.3 $6.91 Million - $10.2 Million
199,151 New
199,151 $6.92 Million

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.02B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.